Third party brands are trademarks of their respective owners. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic.
DATA GUARDIAN 3 ANDROID
The Android robot is reproduced or modified from work created and shared by Google and used according to terms described in the Creative Commons 3.0 Attribution License. and any use of such marks by Medtronic is under license. The Bluetooth ® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. For more details, please consult important safety information. and the appropriate CareLink™ User Guide at. Get Pricing for our document shredding, scanning, and storage services in just seconds. Patients should consult their healthcare providers familiar with the management of diabetes prior to making changes in treatment. NOTE: CareLink™ report data is intended for use as an adjunct in the management of diabetes only and NOT intended to be relied upon by itself. The reports provide information that can be used to identify trends and track daily activities-such as carbohydrates consumed, meal times, insulin delivery, and glucose readings.
DATA GUARDIAN 3 SOFTWARE
The purpose of the software is to take information transmitted from insulin pumps, glucose meters and continuous glucose monitoring systems, and turn it into CareLink™ reports. The CareLink™ software is intended for use as a tool to help manage diabetes. Important Safety Information: CareLink™ Software For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at and important safety information. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. The system requires a functioning mobile electronic device with correct settings. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. Important Safety Information: Guardian™ Connect CGM System
0 kommentar(er)
